• Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • KTO
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • SGSC Global Bootcamp 2021
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • SGSC Demo Day
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • register
  • login
KoreaTechDesk
No Result
View All Result
KoreaTechDesk
No Result
View All Result
Home Health & Bio

Cell2in – Korean Pioneer in Cell Therapy field

KoreaTechDesk Writer by KoreaTechDesk Writer
March 9, 2020
in Health & Bio
11
Cell2in – Korean Pioneer in Cell Therapy field
0
SHARES
203
VIEWS
Share on FacebookShare on Twitter

In recent years the popularity of cell therapy in the field of regenerative medicine has increased tremendously. South Korean company Cell2in is leading the way in the field of cell therapy through its extraordinary Research & Development facility. The start-up has been co-founded by professors of top-ranked universities in South Korea.

The main area of research of Cell2in is to improvise the quality of cells, specially for cell therapy, cell culturing and stem cells. The company is making improvements in regenerative medicine, improved vitality of stem cells and identification of ingredients to enhance cells through cell culture media or be used in cosmetics. The current drawback in the field though is the absence of quality control methods in cell therapy, to evaluate the usefulness of the therapeutics Cell2in intents to resolve this problem through their revolutionary platform technology for quality control assessment in cell therapy.

Cell2in’s platform technology called FreSHtracer is the very first method in the world to safely measure glutathione or GSH level in living cells.

 

Glutathione is most important for fighting harmful oxidants that can damage healthy cells. With the technology by Cell2in scientists can grow and select cells with increased viability. This technology provides a reliable, cost-effective method to monitor the key cellular function in real-time and has a great potential to become an indispensable tool in cell manufacturing and cell therapy, which is widely accepted as the next frontier of medicine.

Source: http://www.cell2in.com

In addition to cell therapy, development of traditional pharmaceutical and cosmetic ingredients with anti-aging effects is another important area where FreSHtracer technology can find its direct applications.

Screening antioxidant activities were never easier before; one can now easily assess compounds’ antioxidant capacities by comparing how fast a cell restore its GSH level with or without the compound treatment. Considering the growing market demands for new antioxidants with potential anti-aging effects, our technology can serve as a fast, reliable method to screen a large number of compounds against various cell types. Development of well-formulated cell culture media is also a big business area where FreSHtracer can be used as a valuable cell quality monitoring tool, thus ensuring clinically acceptable bioprocess for the reproducible production of quality-assured cells.

Cell2in is run by a small team of researchers working hard

to bring in advancement in regenerative medicine field.

To bring their technology to forefront they are constantly looking for financial collaborators to help support costs of research and development. Recently, the company signed a technology agreement with Israel bio company Cellect to strengthen stem cell technology.

Cell2in is charting territories where no other company in the world has gone before. The company’s mission is to advance the field of medicine by developing quality control techniques and treatments through the augmentation of Glutathione in cells. This would mean that treatments like stem cell therapy may become safe and viable options for people suffering from disease.

What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
0
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: anti-agingantioxidantCell TherapyGlutathioneStem Cells
Previous Post

Capture your own Virtual Reality Images

Next Post

Leading the animation world with “Nori” & Friends

Next Post
Leading the animation world with “Nori” & Friends

Leading the animation world with "Nori" & Friends

0 0 votes
Article Rating
Subscribe
Login
Notify of
Please login to comment
11 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
trackback
บุหรี่ไฟฟ้าพร้อมสูบ
5 months ago

… [Trackback]

[…] There you can find 65562 more Info to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
เงินด่วน
5 months ago

… [Trackback]

[…] Find More on on that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
เงินด่วน
5 months ago

… [Trackback]

[…] Info on that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
passive income ideas 2022
4 months ago

… [Trackback]

[…] Info to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
Monero
4 months ago

… [Trackback]

[…] There you will find 66340 more Info on that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
stop screen recording
4 months ago

… [Trackback]

[…] Find More Info here to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
sbobet
3 months ago

… [Trackback]

[…] Find More to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
Alexa Nikolas lies
2 months ago

… [Trackback]

[…] Here you will find 75215 more Info on that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
Jili slot
1 month ago

… [Trackback]

[…] Find More to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
golden teacher mushroom temperature,
26 days ago

… [Trackback]

[…] Info to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
trackback
molly drug benefits,
25 days ago

… [Trackback]

[…] Here you can find 77794 additional Information to that Topic: koreatechdesk.com/cell2in-korean-pioneer-in-cell-therapy-field/ […]

0
No Result
View All Result

Follow Us

FREE NEWSLETTER

Ecosystem Partners




PRODUCTS

Most Popular

  • 10 K-Dramas to watch for some ‘money matters’

    0 shares
    Share 0 Tweet 0
  • UNDP-Citi Foundation’s impact startup acceleration programme ‘Citypreneurs 2023’ to promote innovative solutions for urban sustainability

    0 shares
    Share 0 Tweet 0
  • Top Korean Dating apps that can help you make new connections in South Korea

    1 shares
    Share 0 Tweet 0
  • Three Restaurant Apps to try out for a fine dining experience in South Korea  

    9 shares
    Share 9 Tweet 0
  • Fabless semiconductor startup Fadu raises pre-IPO funding, becomes this year’s first Korean unicorn

    0 shares
    Share 0 Tweet 0
  • Quantit secures  30 billion won Series A investment from Smilegate Holdings for AI-based FinTech Asset Management Services

    0 shares
    Share 0 Tweet 0
  • Korean startup launching a nose-print identification for dogs, an alternate to the microchip embedding process

    0 shares
    Share 0 Tweet 0
  • Korean startups fall short on global readiness, finds Open Innovation Trend survey

    0 shares
    Share 0 Tweet 0
  • Korean government pledges to nurture K-Space startups with 50 billion won ‘space fund’

    0 shares
    Share 0 Tweet 0
  • Afun Interactive receives investment for Virtual K-Pop Content Production

    0 shares
    Share 0 Tweet 0
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2023 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KTO
    • KOTRA
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • Forums
  • register
  • login

Copyright © 2023 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

wpDiscuz
11
0
Would love your thoughts, please comment.x
()
x
| Reply

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback

dgdfgfdgdf

What you think about Koreatechdesk, Share your idea with us!

feedback popup

Invitation submission has been closed

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.